SINEMA Model of Care to Improve the Health of Stroke Patients in Rural China

NCT03185858 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1299

Last updated 2020-09-17

No results posted yet for this study

Summary

Despite the significant burden of stroke in rural China, secondary prevention of stroke is scarce. The aim of the study is to develop a system-integrated technology-enabled intervention (SINEMA) model for the secondary prevention of stroke in rural China and evaluate the effectiveness of the model compared with usual care. The hypothesis is that trained village doctors, equipped with digital health technology, can provide essential evidence-based care to stroke survivors in rural China.

Conditions

Interventions

BEHAVIORAL

SINEMA intervention

Provider-facing intervention includes the following components: (1) Systematic cascade training for village doctors; (2) monthly follow-up visits with the support of the SINEMA APP; (3) village doctor group activities; (4) performance feedback and incentives. Stroke survivor-facing intervention program includes the following components: (1) Briefing session; (2) monthly follow-up visits and follow-up handout; (3) daily voice message for health education.

Sponsors & Collaborators

  • Medical Research Council

    collaborator OTHER_GOV
  • Wellcome Trust

    collaborator OTHER
  • Economic and Social Research Council, United Kingdom

    collaborator OTHER
  • Department for International Development, United Kingdom

    collaborator OTHER_GOV
  • Beijing Tiantan Hospital

    collaborator OTHER
  • China Mobile Research Institute

    collaborator OTHER
  • Xingtai Center for Disease Control and Prevention, China

    collaborator UNKNOWN
  • Centers for Disease Control and Prevention, China

    collaborator OTHER_GOV
  • Duke University

    collaborator OTHER
  • Duke Kunshan University

    lead OTHER

Principal Investigators

  • Lijing L. Yan, PhD · Duke Kunshan Unviersity

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-23
Primary Completion
2018-07-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03185858 on ClinicalTrials.gov